The impact of electrode size on transthoracic impedance and the dose-dependent efficacy of electrical cardioversion for elimination of atrial fibrillation persisting up to 48 hours in patients with ischemic heart disease was tested.
Similar content being viewed by others
References
Fuster V., Rydén L.E., Asinger R.W. et al., J. Am. Coll. Cardiol., 38, No. 4, 1231-1266 (2001).
Link M.S., Atkins D.L., Passman R.S. et al., Circulation, 122, No. 18, Suppl. 3, PP. S706-S719 (2010).
Tacker W.A., Jr. (ed.), Defibrillation of the Heart ICDs, AEDs, and Manual, Mosby-Year Book, St. Louis (1994).
Vostrikov V.A., Razumov K.V., Obshch. Reanimatol., 10, No. 2, 41-49 (2014).
Camm A.J. et al., Eur. Heart J., 31, No. 19, 2369-2429 (2010).
Hoyt R., Grayzel J., Kerber R., Circulation, 64, No. 4, 818-823 (1991).
Kerber R.E., Jensen S.R., Grayzel J. et al., N. Engl. J. Med., 305. No. 12, 658-662 (1981).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Meditsinskaya Tekhnika, Vol. 50, No. 3, May-Jun., 2016, pp. 26-29.
Rights and permissions
About this article
Cite this article
Vostrikov, V.A., Razumov, K.V. & Gorbunov, B.B. Impact of Electrode Size on the Efficacy of Electrical Cardioversion for Paroxysmal Atrial Fibrillation. Biomed Eng 50, 179–183 (2016). https://doi.org/10.1007/s10527-016-9614-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10527-016-9614-2